ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.473,63
1,32%
S&P 500
5.738,17
-0,13%
Dow Jones
42.313,00
0,33%
Euro vs US Dollar
1,11685
-0,07%
Bitcoin
65.841,22
1,01%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Tandem Diabetes Care Inc (TNDM)

  7. Tandem Diabetes Care Inc (TNDM) News

TNDM

Tandem Diabetes Care (TNDM)

Tandem Diabetes Care Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:TNDM
DatumZeitQuelleÜberschriftSymbolFirma
19/09/202415h00Business WireTandem t:slim X2 Insulin Pump Now Compatible with Lyumjev Ultra-rapid Acting Insulin in European UnionNASDAQ:TNDMTandem Diabetes Care Inc
18/09/202423h06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNDMTandem Diabetes Care Inc
26/08/202422h05Business WireTandem Diabetes Care Announces Upcoming Conference ParticipationNASDAQ:TNDMTandem Diabetes Care Inc
20/08/202402h31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNDMTandem Diabetes Care Inc
20/08/202402h31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNDMTandem Diabetes Care Inc
20/08/202402h31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNDMTandem Diabetes Care Inc
20/08/202402h31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNDMTandem Diabetes Care Inc
20/08/202402h31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNDMTandem Diabetes Care Inc
20/08/202400h30Business WireTandem Diabetes Care to Release Updated iOS t:connect Mobile App for t:slim X2 Insulin Pump Users Impacted by March 2024 Nationwide RecallNASDAQ:TNDMTandem Diabetes Care Inc
12/08/202422h30Business WireTandem Diabetes Care Provides Update on March 2024 Nationwide Recall of t:connect Mobile App for iOS DevicesNASDAQ:TNDMTandem Diabetes Care Inc
09/08/202422h52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNDMTandem Diabetes Care Inc
01/08/202422h11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TNDMTandem Diabetes Care Inc
01/08/202422h07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNDMTandem Diabetes Care Inc
01/08/202422h05Business WireTandem Diabetes Care Announces Second Quarter 2024 Financial Results and Increases Full Year 2024 Sales GuidanceNASDAQ:TNDMTandem Diabetes Care Inc
30/07/202422h05Business WireTandem Diabetes Care Announces Upcoming Conference PresentationNASDAQ:TNDMTandem Diabetes Care Inc
29/07/202415h00Business WireTandem Diabetes Care and Dexcom Announce the t:slim X2 Insulin Pump with Dexcom G7 CGM Compatibility is Authorized for Sale by Health CanadaNASDAQ:TNDMTandem Diabetes Care Inc
29/07/202415h00Business WireTandem Diabetes Care et Dexcom annoncent que la pompe à insuline t:slim X2 compatible avec le système de SGC Dexcom G7 est autorisée à la vente par Santé CanadaNASDAQ:TNDMTandem Diabetes Care Inc
17/07/202422h16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNDMTandem Diabetes Care Inc
11/07/202422h05Business WireTandem Diabetes Care to Announce Second Quarter 2024 Financial Results on August 1, 2024NASDAQ:TNDMTandem Diabetes Care Inc
22/06/202417h00Business WireTandem Mobi Improves Quality of Life for People Living With Type 1 Diabetes in New Data Shared at American Diabetes Association Scientific SessionsNASDAQ:TNDMTandem Diabetes Care Inc
20/06/202415h00Business WireTandem Diabetes Care Appoints Jean-Claude Kyrillos as Chief Operating OfficerNASDAQ:TNDMTandem Diabetes Care Inc
18/06/202422h31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNDMTandem Diabetes Care Inc
18/06/202415h00Business WireTandem Diabetes Care to Present New Early User Insights on the Tandem Mobi System at the American Diabetes Association’s 84th Scientific SessionsNASDAQ:TNDMTandem Diabetes Care Inc
13/06/202422h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNDMTandem Diabetes Care Inc
12/06/202423h39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNDMTandem Diabetes Care Inc
11/06/202400h40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNDMTandem Diabetes Care Inc
03/06/202422h22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNDMTandem Diabetes Care Inc
31/05/202423h00Edgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:TNDMTandem Diabetes Care Inc
29/05/202414h30Business WireTandem Mobi Insulin Pump Now Compatible with Dexcom G7 CGMNASDAQ:TNDMTandem Diabetes Care Inc
29/05/202400h45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNDMTandem Diabetes Care Inc
 Showing the most relevant articles for your search:NASDAQ:TNDM

Kürzlich von Ihnen besucht

AMEX
XBOC
Innovator US Equity Acce...
LSE
HERC
Hercules Site Services
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten